2019•Experimental NeurologyOpen access

Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis

John S. Yi, Melissa A. Russo, Shruti M. Raja, Janice M. Massey, Vern C. Juel, Jay W. Shin, Lisa D. Hobson‐Webb, Karissa Gable, Jeffrey T. Guptill

Open full text 18 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 18 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: RAR-related orphan receptor gamma, Orphan receptor, Myasthenia gravis, Retinoic acid, Interleukin 17, Antibody, Transcription factor, Immunology

Back to paper search Browse research topics Original source

Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis — Research Paper | ScholarLens